Lumentum Announces Fiscal Third Quarter 2021 Financial Results
Lumentum Holdings reported fiscal Q3 2021 results, with net revenue of $419.5 million, a 12.4% decrease from the prior quarter but a 4.1% increase year-over-year. GAAP net income was $225.5 million or $2.85 per diluted share. The company highlighted a cash balance of $2,054.6 million, up $354.3 million quarter-over-quarter. Despite deferring $14.8 million in revenue due to 5G deployment delays in China, Lumentum's gross margin improved by 490bps year-over-year. For Q4, guidance estimates net revenue between $360 million to $400 million.
- Net income of $225.5 million reflects strong profitability.
- Gross margin increased to 44.1%, up from 39.2% year-over-year.
- Strong cash position with $2,054.6 million, indicating financial stability.
- Share buyback program approved for up to $700 million, signaling confidence in future growth.
- Net revenue decreased by 12.4% quarter-over-quarter.
- Revenue deferral of $14.8 million due to 5G delays could indicate potential ongoing risks.
SAN JOSE, Calif., May 12, 2021 /PRNewswire/ -- Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported results for its fiscal third quarter ended April 3, 2021, which was a 14-week period.
Net revenue for the fiscal third quarter of 2021, which was reduced by
Non-GAAP net income for the fiscal third quarter of 2021 was
The Company held
"The strong year on year margin improvements in our third quarter results highlight a product portfolio increasingly rich in new and differentiated products that are aligned with multi-year favorable market trends and the impact of continuous improvement in our operations," said Alan Lowe, President and CEO. "Out of an abundance of caution, we deferred
"Based on confidence in our long-term outlook, and our cash balance having increased by more than
Financial Overview – Fiscal Third Quarter Ended April 3, 2021 | |||||||||||||||||||||||||||||
GAAP Results ($ in millions) | |||||||||||||||||||||||||||||
Q3 | Q2 | Q3 | Change | ||||||||||||||||||||||||||
FY 2021 | FY 2021 | FY 2020 | Q/Q | Y/Y | |||||||||||||||||||||||||
Net revenue | $ | 419.5 | $ | 478.8 | $ | 402.8 | (12.4)% | ||||||||||||||||||||||
Gross margin | (390)bps | 490bps | |||||||||||||||||||||||||||
Operating margin | 3,950bps | 5,300bps | |||||||||||||||||||||||||||
Non-GAAP Results ($ in millions) | |||||||||||||||||||||||||||||
Q3 | Q2 | Q3 | Change | ||||||||||||||||||||||||||
FY 2021 | FY 2021 | FY 2020 | Q/Q | Y/Y | |||||||||||||||||||||||||
Net revenue | $ | 419.5 | $ | 478.8 | $ | 402.8 | (12.4)% | ||||||||||||||||||||||
Gross margin | (350)bps | 440bps | |||||||||||||||||||||||||||
Operating margin | (760)bps | 290bps |
Net Revenue by Segment ($ in millions) | |||||||||||||||||||||||||||||||||||
Q3 | % of | Q2 | Q3 | Change | |||||||||||||||||||||||||||||||
FY 2021 | Net Revenue | FY 2021 | FY 2020 | Q/Q | Y/Y | ||||||||||||||||||||||||||||||
Optical Communications | $ | 387.9 | $ | 449.1 | $ | 359.3 | (13.6)% | ||||||||||||||||||||||||||||
Lasers | 31.6 | 29.7 | 43.5 | (27.4)% | |||||||||||||||||||||||||||||||
Total | $ | 419.5 | $ | 478.8 | $ | 402.8 | (12.4)% |
The tables above provide comparisons of quarterly results to prior periods, including sequential quarterly and year-over-year changes. A reconciliation between GAAP and non-GAAP measures is contained in this release under the section titled "Use of Non-GAAP Financial Measures."
Business Outlook
Lumentum expects the following for the fiscal fourth quarter 2021:
- Net revenue in the range of
$360 million to$400 million - Non-GAAP operating margin of
22.5% to25.0% - Non-GAAP diluted earnings per share of
$0.92 to$1.14
We have not provided reconciliations from GAAP to non-GAAP measures for our outlook. A large portion of non-GAAP adjustments, such as restructuring charges, stock-based compensation, non-cash income tax expense and credits, integration related costs, inventory write down due to plans to exit certain product lines and other costs and contingencies unrelated to current and future operations are by their nature highly volatile and we have low visibility as to the range that may be incurred in the future.
Conference Call
Lumentum will host a conference call today, May 12, 2021, at 5:30 am PT/8:30 am ET. A live webcast of the call and the replay will be available on the Lumentum website at http://investor.lumentum.com through May 19, 2021, at 11:59 pm ET. To listen to the live conference call, dial (844) 802-2439 or (412) 902-4275 and reference the passcode 10155696. To access the replay, dial (877) 344-7529 or (412) 317-0088 and reference the passcode 10155696. Supporting materials outlining the Company's latest financial results will be posted on http://investor.lumentum.com under the "Events and Presentations" section concurrently with this earnings press release. Lumentum has used, and intends to continue to use, its Investor Relations website as means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. This press release is being furnished as an exhibit to a Current Report on Form 8-K filed with the Securities and Exchange Commission and will be available at http://www.sec.gov/.
About Lumentum
Lumentum (NASDAQ: LITE) is a market-leading designer and manufacturer of innovative optical and photonic products enabling optical networking and laser applications worldwide. Lumentum optical components and subsystems are part of virtually every type of telecom, enterprise, and data center network. Lumentum lasers enable advanced manufacturing techniques and diverse applications including next-generation 3D sensing capabilities. Lumentum is headquartered in San Jose, California with R&D, manufacturing, and sales offices worldwide. For more information, visit www.lumentum.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These include statements regarding our expectations for our markets, any anticipation or guidance as to demand for our products and technology, and our guidance with respect to future net revenue, earnings per share, and operating margins. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected. Among the factors that could cause actual results to differ from those contemplated are: (a) the COVID-19 pandemic and related impacts, which may continue to adversely impact our business, financial performance and results of operations; (b) quarter-over-quarter product mix fluctuations which can materially impact profitability measures due to the broad gross margin ranges across our portfolio; (c) continued decline of average selling prices across our businesses; (d) effects of seasonality; (e) the ability of our suppliers and contract manufacturers to meet production and delivery requirements for our forecasted demand; (f) inherent uncertainty related to global markets, including the impact of the COVID-19 pandemic, changes in the political or economic environment, including trade and export restrictions and the imposition of tariffs or other duties, and the effect of such markets on demand for our products; (g) changes in customer demand; (h) our ability to attract and retain new customers, particularly in the 3D sensing market; and (i) the risk that Lumentum's financing or operating strategies will not be successful. For more information on these and other risks, please refer to the "Risk Factors" section included in the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended April 3, 2021 to be filed with the Securities and Exchange Commission. The forward-looking statements and preliminary financial results contained in this press release are made as of the date hereof and the Company assumes no obligation to update such statements, except as required by applicable law.
Contact Information
Investors: Jim Fanucchi, 408-404-5400; investor.relations@lumentum.com
Media: Sean Ogarrio, 408-546-5405; media@lumentum.com
Category: Financial
The following financial tables are presented in accordance with GAAP, unless otherwise specified.
LUMENTUM HOLDINGS INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share data) (unaudited) | |||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
April 3, 2021 | March 28, 2020 | April 3, 2021 | March 28, 2020 | ||||||||||||||||||||
Net revenue | $ | 419.5 | $ | 402.8 | $ | 1,350.7 | $ | 1,310.5 | |||||||||||||||
Cost of sales | 218.7 | 231.2 | 684.6 | 757.2 | |||||||||||||||||||
Amortization of acquired developed intangibles | 15.8 | 13.9 | 45.8 | 38.8 | |||||||||||||||||||
Gross profit | 185.0 | 157.7 | 620.3 | 514.5 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research and development | 57.2 | 48.7 | 160.4 | 149.6 | |||||||||||||||||||
Selling, general and administrative | 65.5 | 61.3 | 183.1 | 180.4 | |||||||||||||||||||
Restructuring and related charges | 2.9 | 2.7 | 3.1 | 4.9 | |||||||||||||||||||
Merger termination fee and related costs, net | (207.5) | — | (207.5) | — | |||||||||||||||||||
Impairment charges | — | 2.5 | — | 2.5 | |||||||||||||||||||
Total operating expenses (income) | (81.9) | 115.2 | 139.1 | 337.4 | |||||||||||||||||||
Income from operations | 266.9 | 42.5 | 481.2 | 177.1 | |||||||||||||||||||
Interest expense | (16.4) | (15.6) | (48.7) | (45.3) | |||||||||||||||||||
Other income (expense), net | 2.4 | 21.7 | 2.1 | 27.9 | |||||||||||||||||||
Income before income taxes | 252.9 | 48.6 | 434.6 | 159.7 | |||||||||||||||||||
Provision for income taxes | 27.4 | 5.2 | 58.8 | 19.6 | |||||||||||||||||||
Net income | $ | 225.5 | $ | 43.4 | $ | 375.8 | $ | 140.1 | |||||||||||||||
Net income per share: | |||||||||||||||||||||||
Basic | $ | 2.97 | $ | 0.58 | $ | 4.97 | $ | 1.84 | |||||||||||||||
Diluted | $ | 2.85 | $ | 0.56 | $ | 4.78 | $ | 1.80 | |||||||||||||||
Shares used to compute net income per share: | |||||||||||||||||||||||
Basic | 75.8 | 74.8 | 75.6 | 76.2 | |||||||||||||||||||
Diluted | 79.2 | 77.5 | 78.6 | 77.7 |
LUMENTUM HOLDINGS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in millions, except per share data) (unaudited) | |||||||||||
April 3, 2021 | June 27, 2020 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 687.7 | $ | 298.0 | |||||||
Short-term investments | 1,366.9 | 1,255.8 | |||||||||
Accounts receivable, net | 224.8 | 233.5 | |||||||||
Inventories | 210.7 | 188.9 | |||||||||
Prepayments and other current assets | 79.7 | 73.8 | |||||||||
Total current assets | 2,569.8 | 2,050.0 | |||||||||
Property, plant and equipment, net | 378.0 | 393.0 | |||||||||
Operating lease right-of-use assets, net | 70.3 | 78.7 | |||||||||
Goodwill | 368.9 | 368.9 | |||||||||
Other intangible assets, net | 263.2 | 316.8 | |||||||||
Deferred income taxes | 89.9 | 81.2 | |||||||||
Other non-current assets | 5.8 | 4.0 | |||||||||
Total assets | $ | 3,745.9 | $ | 3,292.6 | |||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 104.7 | $ | 150.8 | |||||||
Accrued payroll and related expenses | 45.9 | 53.4 | |||||||||
Accrued expenses | 39.5 | 23.7 | |||||||||
Convertible notes, current | 385.3 | — | |||||||||
Operating lease liabilities, current | 11.8 | 10.8 | |||||||||
Other current liabilities | 87.0 | 44.3 | |||||||||
Total current liabilities | 674.2 | 283.0 | |||||||||
Convertible notes, non-current | 778.9 | 1,120.3 | |||||||||
Operating lease liabilities, non-current | 50.5 | 57.6 | |||||||||
Deferred tax liability | 31.6 | 46.5 | |||||||||
Other non-current liabilities | 45.7 | 36.0 | |||||||||
Total liabilities | 1,580.9 | 1,543.4 | |||||||||
Commitments and contingencies | |||||||||||
Stockholders' equity: | |||||||||||
Common stock, | 0.1 | 0.1 | |||||||||
Additional paid-in capital | 1,718.8 | 1,676.6 | |||||||||
Retained earnings | 440.4 | 64.6 | |||||||||
Accumulated other comprehensive income | 5.7 | 7.9 | |||||||||
Total stockholders' equity | 2,165.0 | 1,749.2 | |||||||||
Total liabilities and stockholders' equity | $ | 3,745.9 | $ | 3,292.6 |
Use of Non-GAAP Financial Measures
In this press release, Lumentum provides investors with gross margin, gross profit, research and development expense, selling, general and administrative expense, operating margin, operating income, interest and other income (expense), net, income before income taxes, provision for taxes, net income, and net income per share on a non-GAAP basis as well as the non-GAAP measures of EBITDA and Adjusted EBITDA. Lumentum believes this non-GAAP financial information provides additional insight into the Company's on-going business operations and results, as well as cash generation, and has therefore chosen to provide this information to investors for a more consistent basis of comparison and to help them evaluate the results of the Company's on-going operations and enable more meaningful period to period comparisons. In addition, the Company believes that providing certain of these measures allow investors to better understand the Company's cash flows and, importantly, to evaluate the efficacy of the methodology and information used by management to evaluate and measure such cash flows. However, these measures may be different from non-GAAP measures used by other companies, limiting their usefulness for comparison purposes. The non-GAAP financial measures used in this press release should not be considered in isolation from measures of financial performance prepared in accordance with GAAP. Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. In particular, many of the adjustments to our GAAP financial measures reflect the exclusion of items that are recurring and will be reflected in our financial results for the foreseeable future. Further, these non-GAAP financial measures may not be comparable to similarly titled measurements reported by other companies.
Non-GAAP gross margin, non-GAAP gross profit, non-GAAP expenses, non-GAAP operating margin, non-GAAP operating income, non-GAAP income before income taxes, non-GAAP net income, and non-GAAP net income per share and Adjusted EBITDA exclude (i) stock-based compensation, (ii) inventory write-downs and fixed asset impairment due to cancelled programs, plans to exit certain lines of business and other costs and contingencies unrelated to current and future operations, (iii) acquisition and disposition related costs, (iv) integration related costs, (v) amortization of acquired intangibles, (vi) amortization of inventory fair value adjustments, (vii) restructuring and related charges, (viii) non-cash interest expense, (ix) foreign exchange (gains) losses, net, (x) transferring product lines to Thailand, (xi) excess and obsolete inventory charges driven by U.S. trade restrictions and the related decline in demand from Huawei, (xii) non-cash income tax impacts and the incremental cash income tax attributable to the Coherent termination fee, net of transaction costs, and (xiii) the termination fee we received in connection with the termination of our proposed merger agreement with Coherent, net of acquisition related charges. The presentation of these and other similar items in Lumentum's non-GAAP financial results should not be interpreted as implying that these items are non-recurring, infrequent or unusual.
A quantitative reconciliation between GAAP and non-GAAP financial data with respect to historical periods is included in the supplemental financial table attached to this press release.
LUMENTUM HOLDINGS INC. RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES (in millions, except per share data) (unaudited) | |||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||
April 3, 2021 | December 26, 2020 | March 28, 2020 | April 3, 2021 | March 28, 2020 | |||||||||||||||||||||||||||
Gross profit on GAAP basis | $ | 185.0 | $ | 229.6 | $ | 157.7 | $ | 620.3 | $ | 514.5 | |||||||||||||||||||||
Stock-based compensation | 5.3 | 4.8 | 4.3 | 13.8 | 12.6 | ||||||||||||||||||||||||||
Inventory and fixed asset write down due to product line exits (1) | — | 0.1 | 2.3 | 0.4 | 6.0 | ||||||||||||||||||||||||||
Integration related costs | — | — | (0.3) | — | 3.1 | ||||||||||||||||||||||||||
Amortization of acquired intangibles | 15.8 | 15.0 | 13.9 | 45.8 | 38.8 | ||||||||||||||||||||||||||
Amortization of inventory fair value adjustments | — | — | 1.5 | — | 5.8 | ||||||||||||||||||||||||||
Other charges (2) | 3.1 | 6.4 | 4.0 | 20.0 | 25.5 | ||||||||||||||||||||||||||
Gross profit on non-GAAP basis | $ | 209.2 | $ | 255.9 | $ | 183.4 | $ | 700.3 | $ | 606.3 | |||||||||||||||||||||
Gross margin on non-GAAP basis | 49.9 | % | 53.4 | % | 45.5 | % | 51.8 | % | 46.3 | % | |||||||||||||||||||||
Research and development on GAAP basis | $ | 57.2 | $ | 52.8 | $ | 48.7 | $ | 160.4 | $ | 149.6 | |||||||||||||||||||||
Stock-based compensation | (5.3) | (5.1) | (4.2) | (14.8) | (12.1) | ||||||||||||||||||||||||||
Other charges | (0.6) | 0.1 | (0.2) | (0.6) | (0.1) | ||||||||||||||||||||||||||
Research and development on non-GAAP basis | $ | 51.3 | $ | 47.8 | $ | 44.3 | $ | 145.0 | $ | 137.4 | |||||||||||||||||||||
Selling, general and administrative on GAAP basis | $ | 65.5 | $ | 61.3 | $ | 61.3 | $ | 183.1 | $ | 180.4 | |||||||||||||||||||||
Stock-based compensation | (14.5) | (14.2) | (10.7) | (40.1) | (31.4) | ||||||||||||||||||||||||||
Integration related costs | (0.2) | (0.2) | (5.0) | (0.7) | (11.1) | ||||||||||||||||||||||||||
Amortization of acquired intangibles | (6.2) | (5.9) | (6.1) | (17.8) | (18.6) | ||||||||||||||||||||||||||
Other charges | (3.8) | (2.8) | (1.1) | (8.7) | (5.8) | ||||||||||||||||||||||||||
Selling, general and administrative on non-GAAP basis | $ | 40.8 | $ | 38.2 | $ | 38.4 | $ | 115.8 | $ | 113.5 | |||||||||||||||||||||
Income from operations on GAAP basis | $ | 266.9 | $ | 115.3 | $ | 42.5 | $ | 481.2 | $ | 177.1 | |||||||||||||||||||||
Stock-based compensation | 25.1 | 24.1 | 19.2 | 68.7 | 56.1 | ||||||||||||||||||||||||||
Inventory and fixed asset write down due to product line exits (1) | — | 0.1 | 2.3 | 0.4 | 6.0 | ||||||||||||||||||||||||||
Integration related costs | 0.2 | 0.2 | 4.7 | 0.7 | 14.2 | ||||||||||||||||||||||||||
Amortization of acquired intangibles | 22.0 | 20.9 | 20.0 | 63.6 | 57.4 | ||||||||||||||||||||||||||
Amortization of inventory fair value adjustments | — | — | 1.5 | — | 5.8 | ||||||||||||||||||||||||||
Restructuring and related charges | 2.9 | 0.2 | 2.7 | 3.1 | 4.9 | ||||||||||||||||||||||||||
Merger termination fee and related costs, net (3) | (207.5) | — | — | (207.5) | — | ||||||||||||||||||||||||||
Impairment charges (4) | — | — | 2.5 | — | 2.5 | ||||||||||||||||||||||||||
Other charges | 7.5 | 9.1 | 5.3 | 29.3 | 31.4 | ||||||||||||||||||||||||||
Income from operations on non-GAAP basis | $ | 117.1 | $ | 169.9 | $ | 100.7 | $ | 439.5 | $ | 355.4 | |||||||||||||||||||||
Operating margin on non-GAAP basis | 27.9 | % | 35.5 | % | 25.0 | % | 32.5 | % | 27.1 | % | |||||||||||||||||||||
Interest and other income (expense), net on GAAP basis | $ | (14.0) | $ | (17.2) | $ | 6.1 | $ | (46.6) | $ | (17.4) | |||||||||||||||||||||
Other (income) expense adjustments | — | — | (2.0) | — | (2.0) | ||||||||||||||||||||||||||
Gain on sale of product lines | — | (0.1) | (13.8) | (0.5) | (13.8) | ||||||||||||||||||||||||||
Foreign exchange (gains) losses, net | (1.3) | 2.8 | (0.7) | 3.8 | 0.3 | ||||||||||||||||||||||||||
Non-cash interest expense on convertible notes and term loan | 14.8 | 14.7 | 14.0 | 43.9 | 33.3 | ||||||||||||||||||||||||||
Interest and other income (expense), net on non-GAAP basis | $ | (0.5) | $ | 0.2 | $ | 3.6 | $ | 0.6 | $ | 0.4 | |||||||||||||||||||||
Income before income taxes on GAAP basis | $ | 252.9 | $ | 98.1 | $ | 48.6 | $ | 434.6 | $ | 159.7 | |||||||||||||||||||||
Stock-based compensation | 25.1 | 24.1 | 19.2 | 68.7 | 56.1 | ||||||||||||||||||||||||||
Inventory and fixed asset write down due to product line exits (1) | — | 0.1 | 2.3 | 0.4 | 6.0 | ||||||||||||||||||||||||||
Integration related costs | 0.2 | 0.2 | 4.7 | 0.7 | 14.2 | ||||||||||||||||||||||||||
Amortization of acquired intangibles | 22.0 | 20.9 | 20.0 | 63.6 | 57.4 | ||||||||||||||||||||||||||
Amortization of inventory fair value adjustments | — | — | 1.5 | — | 5.8 | ||||||||||||||||||||||||||
Restructuring and related charges | 2.9 | 0.2 | 2.7 | 3.1 | 4.9 | ||||||||||||||||||||||||||
Merger termination fee and related costs, net (3) | (207.5) | — | — | (207.5) | — | ||||||||||||||||||||||||||
Impairment charges (4) | — | — | 2.5 | — | 2.5 | ||||||||||||||||||||||||||
Other (income) expense adjustments | — | — | (2.0) | — | (2.0) | ||||||||||||||||||||||||||
Gain on sale of product lines | — | (0.1) | (13.8) | (0.5) | (13.8) | ||||||||||||||||||||||||||
Foreign exchange (gains) losses, net | (1.3) | 2.8 | (0.7) | 3.8 | 0.3 | ||||||||||||||||||||||||||
Non-cash interest expense on convertible notes and term loan | 14.8 | 14.7 | 14.0 | 43.9 | 33.3 | ||||||||||||||||||||||||||
Other charges | 7.5 | 9.1 | 5.3 | 29.3 | 31.4 | ||||||||||||||||||||||||||
Income before income taxes on non-GAAP basis | $ | 116.6 | $ | 170.1 | $ | 104.3 | $ | 440.1 | $ | 355.8 | |||||||||||||||||||||
Provision for income taxes on GAAP basis | $ | 27.4 | $ | 14.9 | $ | 5.2 | $ | 58.8 | $ | 19.6 | |||||||||||||||||||||
Income tax adjustments | (21.4) | (0.5) | 1.1 | (24.2) | 7.4 | ||||||||||||||||||||||||||
Provision for income taxes on non-GAAP basis | $ | 6.0 | $ | 14.4 | $ | 6.3 | $ | 34.6 | $ | 27.0 | |||||||||||||||||||||
Net income on GAAP basis | $ | 225.5 | $ | 83.2 | $ | 43.4 | $ | 375.8 | $ | 140.1 | |||||||||||||||||||||
Stock-based compensation | 25.1 | 24.1 | 19.2 | 68.7 | 56.1 | ||||||||||||||||||||||||||
Inventory and fixed asset write down due to product line exits (1) | — | 0.1 | 2.3 | 0.4 | 6.0 | ||||||||||||||||||||||||||
Acquisition related costs | — | 1.1 | — | — | — | ||||||||||||||||||||||||||
Integration related costs | 0.2 | 0.2 | 4.7 | 0.7 | 14.2 | ||||||||||||||||||||||||||
Amortization of acquired intangibles | 22.0 | 20.9 | 20.0 | 63.6 | 57.4 | ||||||||||||||||||||||||||
Amortization of inventory fair value adjustments | — | — | 1.5 | — | 5.8 | ||||||||||||||||||||||||||
Restructuring and related charges | 2.9 | 0.2 | 2.7 | 3.1 | 4.9 | ||||||||||||||||||||||||||
Merger termination fee and related costs, net (3) | (207.5) | — | — | (207.5) | — | ||||||||||||||||||||||||||
Impairment charges (4) | — | — | 2.5 | — | 2.5 | ||||||||||||||||||||||||||
Other (income) expense adjustments | — | — | (2.0) | — | (2.0) | ||||||||||||||||||||||||||
Gain on sale of product lines | — | (0.1) | (13.8) | (0.5) | (13.8) | ||||||||||||||||||||||||||
Foreign exchange (gains) losses, net | (1.3) | 2.8 | (0.7) | 3.8 | 0.3 | ||||||||||||||||||||||||||
Non-cash interest expense on convertible notes and term loan | 14.8 | 14.7 | 14.0 | 43.9 | 33.3 | ||||||||||||||||||||||||||
Income tax adjustments | 21.4 | 0.5 | (1.1) | 24.2 | (7.4) | ||||||||||||||||||||||||||
Other charges | 7.5 | 8.0 | 5.3 | 29.3 | 31.4 | ||||||||||||||||||||||||||
Net income on non-GAAP basis | $ | 110.6 | $ | 155.7 | $ | 98.0 | $ | 405.5 | $ | 328.8 | |||||||||||||||||||||
Net income per share on non-GAAP basis | $ | 1.40 | $ | 1.99 | $ | 1.26 | $ | 5.16 | $ | 4.23 | |||||||||||||||||||||
Shares used in per share calculation - | 79.2 | 78.4 | 77.5 | 78.6 | 77.7 |
(1) For the three months ended December 26, 2020 and March 28, 2020, we recorded inventory and fixed asset write down charges of |
(2) Other charges excluded from gross profit on non-GAAP basis for the three and nine months ended April 3, 2021 include costs of transferring product lines to new production facilities, including Thailand of |
Other charges excluded from gross profit on non-GAAP basis for the three months ended December 26, 2020 include costs of transferring product lines to new production facilities, including Thailand of |
(3) For each of the three and nine months ended April 3, 2021, we recorded |
(4) For each of the three and nine months ended March 28, 2020, we recorded impairment charges of |
LUMENTUM HOLDINGS INC. RECONCILIATION OF GAAP NET INCOME TO ADJUSTED EBITDA | |||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||
April 3, 2021 | December 26, 2020 | March 28, 2020 | April 3, 2021 | March 28, 2020 | |||||||||||||||||||||
GAAP Net income | $ | 225.5 | $ | 83.2 | $ | 43.4 | $ | 375.8 | $ | 140.1 | |||||||||||||||
Interest and other expense (income), net | 14.0 | 17.2 | (6.1) | 46.6 | 17.4 | ||||||||||||||||||||
Provision for income taxes | 27.4 | 14.9 | 5.2 | 58.8 | 19.6 | ||||||||||||||||||||
Depreciation | 22.8 | 23.8 | 27.5 | 70.4 | 87.8 | ||||||||||||||||||||
Amortization of acquired intangibles | 22.0 | 20.9 | 20.0 | 63.6 | 57.4 | ||||||||||||||||||||
EBITDA | 311.7 | 160.0 | 90.0 | 615.2 | 322.3 | ||||||||||||||||||||
Amortization of inventory fair value adjustments | — | — | 1.5 | — | 5.8 | ||||||||||||||||||||
Restructuring and related charges | 2.9 | 0.2 | 2.7 | 3.1 | 4.9 | ||||||||||||||||||||
Stock-based compensation | 25.1 | 24.1 | 19.2 | 68.7 | 56.1 | ||||||||||||||||||||
Inventory and fixed asset write down due to product line exits | — | 0.1 | 2.3 | 0.4 | 6.0 | ||||||||||||||||||||
Integration related costs | 0.2 | 0.2 | 4.7 | 0.7 | 14.2 | ||||||||||||||||||||
Merger termination fee and related costs, net | (207.5) | — | — | (207.5) | — | ||||||||||||||||||||
Impairment charges | — | — | 2.5 | — | 2.5 | ||||||||||||||||||||
Other charges | 7.5 | 9.1 | 5.3 | 29.3 | 31.4 | ||||||||||||||||||||
Adjusted EBITDA | $ | 139.9 | $ | 193.7 | $ | 128.2 | $ | 509.9 | $ | 443.2 |
View original content:http://www.prnewswire.com/news-releases/lumentum-announces-fiscal-third-quarter-2021-financial-results-301289340.html
SOURCE Lumentum
FAQ
What were Lumentum's earnings for fiscal Q3 2021?
How did Lumentum's revenue perform compared to previous quarters?
What is Lumentum's guidance for fiscal Q4 2021?
What factors impacted Lumentum's financial results in Q3 2021?